| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement wi...
Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.
Saudi Arabia has committed to purchasing hundreds of U.S.-made tanks, underlining an expansive defense and economic partnership...
https://www.bloomberg.com/news/articles/2025-11-18/pfizer-kicks-off-us-dollar-bond-sale-to-help-fund-metsera-deal
Novo Nordisk's new chair Lars Sorensen plans to add pharma expertise and address governance concerns after a major board ov...
Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com...
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.
Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesi...